Pfizer Inc | Page 2 | The Business Standard
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
SATURDAY, MAY 28, 2022
SATURDAY, MAY 28, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা

Pfizer Inc

Pfizer's logo is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. REUTERS/Dado Ruvic/Illustration
Coronavirus chronicle

Pfizer offers 40m Covid shots to poorer countries at cost

Covax — the globally-pooled coronavirus vaccine procurement and equitable distribution effort, aimed at ensuring that lower-income countries get hold of doses too — is hoping to ship its first...

What's next for Pfizer's Covid-19 vaccine after UK rollout
Coronavirus chronicle

What's next for Pfizer's Covid-19 vaccine after UK rollout

Pfizer's logo is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. REUTERS/Dado Ruvic/Illustration
Coronavirus chronicle

Pfizer, BioNTech initial vaccine results impress, but scientists remain cautious

A woman holds a small bottle labeled with a "Coronavirus Covid-19 Vaccine" sticker and a medical syringe in front of displayed Pfizer logo in this illustration taken, October 30, 2020. REUTERS/Dado Ruvic/File Photo
Coronavirus chronicle

Why Pfizer’s ultra-cold Covid-19 vaccine will not be at the local pharmacy any time soon

A logo for Pfizer is displayed on a monitor on the floor at the New York Stock Exchange (NYSE) in New York, US, July 29, 2019/ Reuters
Coronavirus chronicle

Pfizer targets end of October for Covid-19 vaccine update

A logo for Pfizer is displayed on a monitor on the floor at the New York Stock Exchange (NYSE) in New York, US, July 29, 2019/ Reuters
Coronavirus chronicle

Pfizer signs deal to supply Gilead's remdesivir for Covid-19

Takenobu Tonegawa, 41, who owns a video production firm, cycles as he works his part-time job as Uber Eats delivery person amid the coronavirus disease (Covid-19) outbreak, in Tokyo, Japan July 16, 2020. Picture taken July 16, 2020. Photo:Reuters
Coronavirus chronicle

Pfizer, BioNTech to supply 120 mln doses of coronavirus vaccine to Japan

A logo for Pfizer is displayed on a monitor on the floor at the New York Stock Exchange (NYSE) in New York, US, July 29, 2019. REUTERS/Brendan McDermid
Global Economy

Pfizer profit falls 32% as global trial of Covid-19 vaccine candidate begins

Small bottles labeled with a "Vaccine Covid-19" sticker and a medical syringe are seen in this illustration taken taken April 10, 2020/ Reuters
Coronavirus chronicle

EU talks with Pfizer, Sanofi, J&J on Covid vaccines hit snags - sources

FILE PHOTO: US Secretary of Health and Human Services Alex Azar speaks during a news briefing on the administration's response to the coronavirus at the White House in Washington, US, March 15, 2020. REUTERS/Joshua Roberts
Coronavirus chronicle

Vaccines sponsored by the US government will be free or affordable - health secretary

File Photo: Small bottles labeled with a "Vaccine Covid-19" sticker and a medical syringe are seen in this illustration taken April 10, 2020. Reuters/Dado Ruvic/Illustration/File Photo
Coronavirus chronicle

Pfizer, BioNTech's coronavirus vaccine candidates get FDA's 'fast track' status

A logo for Pfizer is displayed on a monitor on the floor at the New York Stock Exchange (NYSE) in New York, US, July 29, 2019. REUTERS/Brendan McDermid
World+Biz

Pfizer's hemophilia gene therapy shows sustained effect in early-stage study

A logo for Pfizer is displayed on a monitor on the floor at the New York Stock Exchange (NYSE) in New York, US, July 29, 2019. REUTERS/Brendan McDermid
Coronavirus chronicle

Pfizer to invest up to $500 million in public drug developers

  • Show More
The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab